Brivex, Tabletten

7680554650024 CH-55465 Tabletten

Associated product:

BRIVEX cpr 125 mg 7 pce
Brivex, Tabletten
Brivex, Tabletten
Brivex, Tabletten
1 / 3
google

Article details

Package size
7
Selling units
7
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
28/06/2022
Summary of Product Characteristics
Français
28/06/2022
Summary of Product Characteristics
Italien
28/06/2022
Patient information leaflet
Allemand
23/06/2022
Patient information leaflet
Français
23/06/2022
Patient information leaflet
Italien
23/06/2022

Detailed composition

Substance Quantity Type Category
(N/A)
125.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
37.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 82.65
Specialties list
Yes
Generic
No
SL addition date: 01/07/2003

Authorization holder

A. Menarini GmbH

8050 Zürich

Authorization information

Swissmedic authorization number
55465
Drug name
Brivex, Tabletten
Galenic form
TAB
ATC Code
J05AB15
Authorization status
Z
Dispensing category
A
First authorization
16/05/2003
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Herpesinfektionen

Package details

Description (FR)
BRIVEX cpr 125 mg 7 pce
Description (DE)
BRIVEX Tabl 125 mg 7 Stk
Market launch
16/05/2003
Narcotic (BTM)
No

Other package sizes (1)

None
1 TABL
GTIN: None
Not in V1